2m 2m 2m 2m 2m 2m 2m
Lite Strategy (LITS)
NASDAQ
$1.39+$0.01 (+0.73%)
Price as of Oct 02, 2026 6:37 PM EDT- $41.8MMarket Cap
- -48.69%1-Year Change
- BiotechnologyIndustry
Lite Strategy (LITS)
$1.39+$0.01 (+0.73%)
LITS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.38 | ||
Change | +$0.05 (+4.17%) | ||
Open | $1.31 | ||
High | $1.41 | ||
Low | $1.28 | ||
Previous Close | $1.32 | ||
Volume | 1,036,838 | ||
30-Day Average Volume | 927,132 | ||
1-Week Change | -3.85% | ||
1-Month Change | 38.33% | ||
1-Year Change | -48.69% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 30.4M | ||
Total Assets | $42.7M | ||
Market Cap | $41.8M | ||
Enterprise Value | $36.1M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$13.0M | ||
Free Cash Flow | -$1.2M | ||
EBIT | -$13.0M | ||
EBITDA | -$13.0M | ||
Net Working Capital | $5.1M | ||
EPS | -$0.36 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -36 | ||
Price/Operating Cash Flow | -36 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue